A Novel Patient-Tailored, Cumulative Neurotechnology-Based Therapy for Upper-Limb Rehabilitation in Severely Impaired Chronic Stroke Patients: The AVANCER Study Protocol
Claudia Bigoni, Sarah B. Zandvliet, Elena Beanato, Andrea Crema, Martina Coscia, Arnau Espinosa, Tina Henneken, Julie Hervé, Meltem Oflar, Giorgia G. Evangelista, Takuya Morishita, Maximilian J. Wessel, Christoph Bonvin, Jean-Luc Turlan, Niels Birbaumer, Friedhelm C. Hummel
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 July 2022.
All research outputs
#13,393,139
of 22,867,327 outputs
Outputs from Frontiers in Neurology
#5,179
of 11,795 outputs
Outputs of similar age
#176,406
of 434,826 outputs
Outputs of similar age from Frontiers in Neurology
#189
of 781 outputs
Altmetric has tracked 22,867,327 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,795 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,826 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 781 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.
